Shrinking COVID vaccine sales has Moderna course-correcting
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
There’s potential that a stem cell infusion from kidney donors might help prevent organ rejection — allowing patients to perhaps wean from immunosuppressive drugs. We see the Senate is getting serious about PBMs, and have a neat podcast, as always. Have a good weekend!
Read Original Article: Shrinking COVID vaccine sales has Moderna course-correcting »
